AKT1 and cancer: Besides functional differences, loss of RANBP3L is accompanied by a massive shift towards a gene expression profile that is linked to different cancer-associated pathways including the phosphatidylinositol 3 kinase (PI3K)/Akt, EMT or TGF-β signaling cascades.